Antileishmanial agent-29
Antileishmanial agent-29 (Compound 110) is an orally active compound that exhibits antileishmanial properties. It can protect mice from Leishmania infection when administered orally at doses of 40 or 60 mg/kg over a period of 10 days.
Product Specifications
Field of Research
Infectious Disease & Virology
Molecular Formula
C20H29N3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1224561-01 0.02 mg (E-Coli)
Recombinant Mycobacterium marinum Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1224561-02 0.02 mg (Yeast)
Recombinant Mycobacterium marinum Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1224561-03 0.1 mg (E-Coli)
Recombinant Mycobacterium marinum Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1224561-04 0.1 mg (Yeast)
Recombinant Mycobacterium marinum Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1224561-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium marinum Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details MBS1224561-06 0.02 mg (Mammalian-Cell)
Recombinant Mycobacterium marinum Histidine--tRNA ligase (hisS)
Sign In for Pricing
View Details